Integrative Analysis of Neuregulin Family Members-Related Tumor Microenvironment for Predicting the Prognosis in Gliomas

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2021 May 31

PMID 34054873

Citations 23

Authors

Wei-Jiang Zhao

Guan-Yong Ou

Wen-Wen Lin

Affiliations

Soon will be listed here.

Abstract

Gliomas, including brain lower grade glioma (LGG) and glioblastoma multiforme (GBM), are the most common primary brain tumors in the central nervous system. Neuregulin (NRG) family proteins belong to the epidermal growth factor (EGF) family of extracellular ligands and they play an essential role in both the central and peripheral nervous systems. However, roles of NRGs in gliomas, especially their effects on prognosis, still remain to be elucidated. In this study, we obtained raw counts of RNA-sequencing data and corresponding clinical information from 510 LGG and 153 GBM samples from The Cancer Genome Atlas (TCGA) database. We analyzed the association of NRG1-4 expression levels with tumor immune microenvironment in LGG and GBM. GSVA (Gene Set Variation Analysis) was performed to determine the prognostic difference of NRGs gene set between LGG and GBM. ROC (receiver operating characteristic) curve and the nomogram model were constructed to estimate the prognostic value of NRGs in LGG and GBM. The results demonstrated that NRG1-4 were differentially expressed in LGG and GBM in comparison to normal tissue. Immune score analysis revealed that NRG1-4 were significantly related to the tumor immune microenvironment and remarkably correlated with immune cell infiltration. The investigation of roles of mA (N6-methyladenosine, mA)-related genes in gliomas revealed that NRGs were prominently involved in mA RNA modification. GSVA score showed that NRG family members are more associated with prognosis in LGG compared with GBM. Prognostic analysis showed that NRG3 and NRG1 can serve as potential independent biomarkers in LGG and GBM, respectively. Moreover, GDSC drug sensitivity analysis revealed that NRG1 was more correlated with drug response compared with other NRG subtypes. Based on these public databases, we preliminarily identified the relationship between NRG family members and tumor immune microenvironment, and the prognostic value of NRGs in gliomas. In conclusion, our study provides comprehensive roles of NRG family members in gliomas, supporting modulation of NRG signaling in the management of glioma.

Citing Articles

STEAP3 is a potential preliminary prognostic biomarker of glioblastoma.

Zhang W, Xie M, Huang Q, Liu H, Liu J, Sun X Sci Rep. 2024; 14(1):30994.

PMID: 39730631 PMC: 11681130. DOI: 10.1038/s41598-024-82145-9.

SOX13 as a potential prognostic biomarker linked to immune infiltration and ferroptosis inhibits the proliferation, migration, and metastasis of thyroid cancer cells.

Ma Y, Zhou W, Qian Y, Mu Y, Zhang W Front Immunol. 2024; 15:1478395.

PMID: 39726600 PMC: 11670200. DOI: 10.3389/fimmu.2024.1478395.

Genomic and transcriptomic profiling of pre- and postneoadjuvant chemotherapy triple negative breast cancer tumors.

Nishimura T, Velaga R, Masuda N, Kawaguchi K, Kawaguchi S, Takada M Cancer Sci. 2024; 115(12):3928-3942.

PMID: 39375938 PMC: 11611771. DOI: 10.1111/cas.16339.

Decoding the immune microenvironment: unveiling CD8 + T cell-related biomarkers and developing a prognostic signature for personalized glioma treatment.

Lin X, Liu J, Zhang N, Zhou D, Liu Y Cancer Cell Int. 2024; 24(1):331.

PMID: 39354483 PMC: 11443942. DOI: 10.1186/s12935-024-03517-9.

Molecular subtypes based on immunologic and epithelial-mesenchymal transition gene sets reveal tumor immune microenvironment characteristics and implications for immunotherapy of patients with glioma.

Lin W, Zhao W, Ou G Heliyon. 2024; 10(17):e36986.

PMID: 39319121 PMC: 11419884. DOI: 10.1016/j.heliyon.2024.e36986.

References

Magnon C, Hall S, Lin J, Xue X, Gerber L, Freedland S . Autonomic nerve development contributes to prostate cancer progression. Science. 2013; 341(6142):1236361. DOI: 10.1126/science.1236361. View

Veatch J, Jesernig B, Kargl J, Fitzgibbon M, Lee S, Baik C . Endogenous CD4 T Cells Recognize Neoantigens in Lung Cancer Patients, Including Recurrent Oncogenic and () Driver Mutations. Cancer Immunol Res. 2019; 7(6):910-922. PMC: 6584616. DOI: 10.1158/2326-6066.CIR-18-0402. View

Long L, Anderson P, Frank E, Shaw A, Liu S, Huang X . Neuregulin 1 expression and electrophysiological abnormalities in the Neuregulin 1 transmembrane domain heterozygous mutant mouse. PLoS One. 2015; 10(5):e0124114. PMC: 4437646. DOI: 10.1371/journal.pone.0124114. View

Auezova R, Ryskeldiev N, Doskaliyev A, Kuanyshev Y, Zhetpisbaev B, Aldiyarova N . Association of preoperative levels of selected blood inflammatory markers with prognosis in gliomas. Onco Targets Ther. 2016; 9:6111-6117. PMC: 5067007. DOI: 10.2147/OTT.S113606. View

Lee C, Yelensky R, Jooss K, Chan T . Update on Tumor Neoantigens and Their Utility: Why It Is Good to Be Different. Trends Immunol. 2018; 39(7):536-548. PMC: 7954132. DOI: 10.1016/j.it.2018.04.005. View

Zhang S, Zhao B, Zhou A, Lin K, Zheng S, Lu Z . mA Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program. Cancer Cell. 2017; 31(4):591-606.e6. PMC: 5427719. DOI: 10.1016/j.ccell.2017.02.013. View

Lin W, Ou G, Lin J, Yi S, Yao W, Pan H . Neuregulin 1 enhances cell adhesion molecule L1 like expression levels and promotes malignancy in human glioma. Oncol Lett. 2020; 20(1):326-336. PMC: 7285836. DOI: 10.3892/ol.2020.11548. View

Aguilar Z, Akita R, Finn R, Ramos B, Pegram M, Kabbinavar F . Biologic effects of heregulin/neu differentiation factor on normal and malignant human breast and ovarian epithelial cells. Oncogene. 1999; 18(44):6050-62. DOI: 10.1038/sj.onc.1202993. View

Sturm G, Finotello F, List M . Immunedeconv: An R Package for Unified Access to Computational Methods for Estimating Immune Cell Fractions from Bulk RNA-Sequencing Data. Methods Mol Biol. 2020; 2120:223-232. DOI: 10.1007/978-1-0716-0327-7_16. View

10.

Cortini M, Avnet S, Baldini N . Mesenchymal stroma: Role in osteosarcoma progression. Cancer Lett. 2017; 405:90-99. DOI: 10.1016/j.canlet.2017.07.024. View

11.

Bapat A, Hostetter G, Von Hoff D, Han H . Perineural invasion and associated pain in pancreatic cancer. Nat Rev Cancer. 2011; 11(10):695-707. DOI: 10.1038/nrc3131. View

12.

Qian B, Pollard J . Macrophage diversity enhances tumor progression and metastasis. Cell. 2010; 141(1):39-51. PMC: 4994190. DOI: 10.1016/j.cell.2010.03.014. View

13.

Perlin J, Lush M, Stephens W, Piotrowski T, Talbot W . Neuronal Neuregulin 1 type III directs Schwann cell migration. Development. 2011; 138(21):4639-48. PMC: 3190382. DOI: 10.1242/dev.068072. View

14.

Ajithkumar T, Taylor R, Kortmann R . Radiotherapy in the Management of Paediatric Low-Grade Gliomas. Clin Oncol (R Coll Radiol). 2018; 31(3):151-161. DOI: 10.1016/j.clon.2018.11.032. View

15.

Leung W, Roxanis I, Sheldon H, Buffa F, Li J, Harris A . Combining lapatinib and pertuzumab to overcome lapatinib resistance due to NRG1-mediated signalling in HER2-amplified breast cancer. Oncotarget. 2015; 6(8):5678-94. PMC: 4467394. DOI: 10.18632/oncotarget.3296. View

16.

Zhao Y, He J, Li Y, Lv S, Cui H . NUSAP1 potentiates chemoresistance in glioblastoma through its SAP domain to stabilize ATR. Signal Transduct Target Ther. 2020; 5(1):44. PMC: 7174393. DOI: 10.1038/s41392-020-0137-7. View

17.

De Keulenaer G, Feyen E, Dugaucquier L, Shakeri H, Shchendrygina A, Belenkov Y . Mechanisms of the Multitasking Endothelial Protein NRG-1 as a Compensatory Factor During Chronic Heart Failure. Circ Heart Fail. 2019; 12(10):e006288. DOI: 10.1161/CIRCHEARTFAILURE.119.006288. View

18.

Quail D, Joyce J . Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013; 19(11):1423-37. PMC: 3954707. DOI: 10.1038/nm.3394. View

19.

Yu G, Wang L, Han Y, He Q . clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012; 16(5):284-7. PMC: 3339379. DOI: 10.1089/omi.2011.0118. View

20.

Liu Y, Cao X . Immunosuppressive cells in tumor immune escape and metastasis. J Mol Med (Berl). 2015; 94(5):509-22. DOI: 10.1007/s00109-015-1376-x. View